23 September 2021 |

Raffles FO leads Hong Kong biotech firm Cellomics’ series B round

(from left): Cellomics co-founder and chairman, professor Michael Yang; RFO Group CEO and co­founder Kwan Chi Man; and Jacobson Pharma executive director Raymond Yim.
Text size
To access this content, please login or enquire for a free trial.To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email help@asianprivatebanker.com.